These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
258 related articles for article (PubMed ID: 1656783)
1. Interaction of nitric oxide and cGMP with signal transduction in activated platelets. Nguyen BL; Saitoh M; Ware JA Am J Physiol; 1991 Oct; 261(4 Pt 2):H1043-52. PubMed ID: 1656783 [TBL] [Abstract][Full Text] [Related]
2. Human platelet signaling defect characterized by impaired production of inositol-1,4,5-triphosphate and phosphatidic acid and diminished Pleckstrin phosphorylation: evidence for defective phospholipase C activation. Yang X; Sun L; Ghosh S; Rao AK Blood; 1996 Sep; 88(5):1676-83. PubMed ID: 8781423 [TBL] [Abstract][Full Text] [Related]
3. Characterization of the inhibition of U46619-mediated human platelet activation by the trimetoquinol isomers. Evidence for endoperoxide/thromboxane A2 receptor blockade. Ahn CH; Romstedt KJ; Wallace LJ; Miller DD; Feller DR Biochem Pharmacol; 1988 Aug; 37(15):3023-33. PubMed ID: 3134894 [TBL] [Abstract][Full Text] [Related]
4. Cyclic GMP analogs inhibit gamma thrombin-induced arachidonic acid release in human platelets. Sane DC; Bielawska A; Greenberg CS; Hannun YA Biochem Biophys Res Commun; 1989 Dec; 165(2):708-14. PubMed ID: 2557018 [TBL] [Abstract][Full Text] [Related]
5. KRDS, a peptide derived from human lactotransferrin, inhibits thrombin-induced thromboxane synthesis by a cyclooxygenase-independent mechanism. Lévy-Toledano S; Grelac F; Caen JP; Maclouf J Thromb Haemost; 1995 May; 73(5):857-61. PubMed ID: 7482416 [TBL] [Abstract][Full Text] [Related]
6. Inhibition by sodium nitroprusside or PGE1 of tyrosine phosphorylation induced in platelets by thrombin or ADP. Oda A; Druker BJ; Smith M; Salzman EW Am J Physiol; 1992 Mar; 262(3 Pt 1):C701-7. PubMed ID: 1372480 [TBL] [Abstract][Full Text] [Related]
7. Impaired nitric oxide-dependent cyclic guanosine monophosphate generation in glomeruli from diabetic rats. Evidence for protein kinase C-mediated suppression of the cholinergic response. Craven PA; Studer RK; DeRubertis FR J Clin Invest; 1994 Jan; 93(1):311-20. PubMed ID: 7506712 [TBL] [Abstract][Full Text] [Related]
8. The phospholipase C inhibitor U73122 inhibits phorbol ester-induced platelet activation. Lockhart LK; McNicol A J Pharmacol Exp Ther; 1999 May; 289(2):721-8. PubMed ID: 10215645 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of platelet arachidonic acid liberation by endothelium-derived relaxing factor (EDRF) as studied with sin-1, a nitric oxide generating drug. Evidence for calcium-dependent and calcium-independent mechanisms. Gassama-Diagne A; Simon MF; Chap H J Lipid Mediat; 1992 Feb; 5(1):61-75. PubMed ID: 1327266 [TBL] [Abstract][Full Text] [Related]
10. Indirect regulation of Ca2+ entry by cAMP-dependent and cGMP-dependent protein kinases and phospholipase C in rat platelets. Heemskerk JW; Feijge MA; Sage SO; Walter U Eur J Biochem; 1994 Jul; 223(2):543-51. PubMed ID: 8055924 [TBL] [Abstract][Full Text] [Related]
11. Ni2+ impairs thrombin-induced signal transduction by acting on the agonist and/or receptor in human platelets. Azula FJ; Alonso R; Marino A; Trueba M; Macarulla JM Am J Physiol; 1993 Dec; 265(6 Pt 1):C1681-8. PubMed ID: 8279529 [TBL] [Abstract][Full Text] [Related]
12. Synthesis of intracellular histamine in platelets is associated with activation of protein kinase C, but not with mobilization of Ca2+. Saxena SP; Robertson C; Becker AB; Gerrard JM Biochem J; 1991 Jan; 273(Pt 2)(Pt 2):405-8. PubMed ID: 1899334 [TBL] [Abstract][Full Text] [Related]
13. Ca2+ mobilization primes protein kinase C in human platelets. Ca2+ and phorbol esters stimulate platelet aggregation and secretion synergistically through protein kinase C. Siess W; Lapetina EG Biochem J; 1988 Oct; 255(1):309-18. PubMed ID: 3143357 [TBL] [Abstract][Full Text] [Related]
14. Characterization of a new compound, S35b, as a guanylate cyclase activator in human platelets. Ghigo D; Heller R; Calvino R; Alessio P; Fruttero R; Gasco A; Bosia A; Pescarmona G Biochem Pharmacol; 1992 Mar; 43(6):1281-8. PubMed ID: 1348617 [TBL] [Abstract][Full Text] [Related]
15. Regulation of protease-activated receptor (PAR) 1 and PAR4 signaling in human platelets by compartmentalized cyclic nucleotide actions. Bilodeau ML; Hamm HE J Pharmacol Exp Ther; 2007 Aug; 322(2):778-88. PubMed ID: 17525299 [TBL] [Abstract][Full Text] [Related]
16. Lysophosphatidic acid can activate platelets without increasing 32P-labelling of phosphatidic acid. Gerrard JM; Robinson P Biochim Biophys Acta; 1984 Oct; 795(3):487-92. PubMed ID: 6433985 [TBL] [Abstract][Full Text] [Related]
17. Inhibitory effect of GBH on platelet aggregation through inhibition of intracellular Ca2+ mobilization in activated human platelets. Park WH; Kim HK; Nam KS; Shon YH; Jeon BH; Moon SK; Kim MG; Kim CH Life Sci; 2004 Nov; 75(25):3063-76. PubMed ID: 15474558 [TBL] [Abstract][Full Text] [Related]
18. Endothelium-derived relaxing factor inhibits thrombin-induced platelet aggregation by inhibiting platelet phospholipase C. Durante W; Kroll MH; Vanhoutte PM; Schafer AI Blood; 1992 Jan; 79(1):110-6. PubMed ID: 1309423 [TBL] [Abstract][Full Text] [Related]
19. Thromboxane-insensitive dog platelets have impaired activation of phospholipase C due to receptor-linked G protein dysfunction. Johnson GJ; Leis LA; Dunlop PC J Clin Invest; 1993 Nov; 92(5):2469-79. PubMed ID: 8227362 [TBL] [Abstract][Full Text] [Related]
20. Correlation between platelet aggregation and dephosphorylation of a 68 kDa protein revealed through the use of putative PKC inhibitors. Turini ME; Gaudette DC; Holub BJ; Kirkland JB Thromb Haemost; 1993 Oct; 70(4):648-53. PubMed ID: 7509513 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]